Cytosorbents Corporation (CTSO) analyst actions
Rating and price-target actions on CTSO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CTSO overview →
1 measured CTSO analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review | Press release | +3.77% | -1.89% |
Keep exploring
More CTSO: earnings → · SEC filings → · CTSO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| argenx SE - American Depositary Shares (ARGX) | 249 | -0.02% | 48% |
| Array Technologies, Inc. (ARRY) | 249 | -0.24% | 41% |
| IRIDEX Corporation (IRIX) | 248 | +0.11% | 52% |
| Kala Pharmaceuticals, Inc. (KALA) | 248 | +0.41% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.